SavedAdd your journal

Journals / Retina-Vitreus / 2011 / Cilt: 19 - Sayı: 2

Other diseases and serous retinal detachment

Diğer hastalıklar ve seröz retina dekolmanları

Berkant KADERLİ
Pages
86–89
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

In this review, congenital and developmental ocular diseases as well as tumors of the retina and choroid are discussed as causes of serous retinal detachment.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Serous or exudative retinal detachment is a common finding of a wide variety of local and systemic diseases.
📊
Key Findings & Data:The main cause of subretinal fluid accumulation is damage to the blood-retina barrier.
💡
Conclusion & Impact:In this review, congenital and developmental ocular diseases as well as tumors of the retina and choroid are discussed as causes of serous retinal detachment.
🔬Design:Review & Systematic Survey
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Serous or exudative retinal detachment is a common finding of a wide variety of local and systemic diseases. The main cause of subretinal fluid accumulation is damage to the blood-retina barrier. In this review, congenital and developmental ocular diseases as well as tumors of the retina and choroid are discussed as causes of serous retinal detachment.

Özet

Seröz veya eksudatif retina dekolmanı, birçok lokal ve sistemik hastalığın ortak bulgusudur. Subretinal sıvı birikiminin temel sebebi kan-retina engelinin bozulmasıdır. Bu derlemede, retina ve koroid tümörlerinin yanı sıra gözün konjenital ve gelişimsel hastalıkları da seröz retina dekolmanının nedenleri olarak tartışılmaktadır.

🔖

Cite This Article

KADERLİ, B. (2011). Other diseases and serous retinal detachment. Retina-Vitreus, Cilt: 19 - Sayı: 2, 86–89. https://ajindex.com/articles/305133

References (16)

  1. Anand R.: Serous detachment of the neural retina. In: Yanoff M, Duker JS: Ophthalmology. 1st ed. London: Mosby Int. Ltd. 1999;P:1-40
  2. Gelişken Ö, Kaderli B.: Coats’ hastalığı. Ret-Vit. 2004;12:148-151
  3. Othman IS, Moussa M, Bouhaimed M.: Management of lipid exudates in Coats disease by adjuvant intravitreal triamcinolone: effects and complications. Br J Ophthalmol. 2010;94:606-610
  4. Kaul S, Uparkar M, Mody K, et al.: Intravitreal anti-vascular endothelial growth factor agents as an adjunct in the management of Coats’ disease in children. Indian J Ophthalmol. 2010;58:76-78
  5. Lin CJ, Hwang JF, Chen YT, et al.: The effect of intravitreal bevacizumab in the treatment of Coats disease in children. Retina. 2010;30:617-622
  6. Sobol WM, Blodi CF, Folk JC, et al.: Long-term visual outcome in patients with optic nerve pit and serous retinal detachment of the macula. Ophthalmology. 1990;97:1539-1542
  7. Imamura Y, Zweifel SA, Fujiwara T, et al.: High-resolution optical coherence tomography findings in optic pit maculopathy. Retina. 2010;30:1104-1112
  8. Johnson TM, Johnson MW.: Pathogenic implications of subretinal gas migration through pits and atypical colobomas of the optic nerve. Arch Ophthalmol. 2004;122:1793-800
  9. Elagouz M, Stanescu-Segall D, Jackson TL.: Uveal effusion syndrome. Surv Ophthalmol. 2010;55:134-145
  10. Gibran SK, Kapoor KG.: Management of exudative retinal detachment in choroidal melanoma. Clin Experiment Ophthalmol. 2009;37:654-659
  11. Blasi MA, Tiberti AC, Scupola A, et al.: Photodynamic therapy with verteporfin for symptomatic circumscribed choroidal hemangioma: five-year outcomes. Ophthalmology. 2010;117:1630-1637
  12. Pilotto E, Urban F, Parrozzani R, et al.: Standard versus bolus photodynamic therapy in circumscribed choroidal hemangioma: functional outcomes. Eur J Ophthalmol. 2011
  13. Tsipursky MS, Golchet PR, Jampol LM.: Photodynamic therapy of choroidal hemangioma in sturge-weber syndrome, with a review of treatments for diffuse and circumscribed choroidal hemangiomas. Surv Ophthalmol. 2011;56:68-85
  14. Sagong M, Lee J, Chang W.: Application of intravitreal bevacizumab for circumscribed choroidal hemangioma. Korean J Ophthalmol. 2009;23:127-131
  15. Mennel S, Peter S, Schmidt JC, et al.: Current treatment indications and treatment options for retinal astrocytic hamartoma. Ophthalmologe. 2010;107:377-378
  16. Chong JT, Mick A.: Choroidal metastasis: case reports and review of the literature. Optometry. 2005;76:293-301.